
71.15 Delayed Data As of Mar 21 | ![]() Today’s Change | 45.25 Today|||52-Week Range 83.95 | +6.51% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $1.3B |
Ligand Pharmaceuticals, Inc. 3911 Sorrento Valley Boulevard San Diego California 92121 |
Todd C. Davis | Chief Executive Officer & Director |
Matthew Edward Korenberg | President & Chief Operating Officer |
Octavio Espinoza | Chief Financial Officer |
Simon Latimer | Investors Relations Manager |
Audrey Warfield-Graham | Chief People Officer |